A new drug for treating Duchenne muscular dystrophy with exon 45 skipping—Casimersen

doi:10.3969/j.issn.1672-3384.2022.05.004

PDF(383 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (5) : 17-20. DOI: 10.3969/j.issn.1672-3384.2022.05.004

Comment of New Drug

A new drug for treating Duchenne muscular dystrophy with exon 45 skipping—Casimersen

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(5): 17-20 https://doi.org/10.3969/j.issn.1672-3384.2022.05.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(383 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-12-29	2022-06-06
Issue Date
2022-06-06

Please choose a citation manager

Content to export